Bumetanide Impurity; 28328-60-1
WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com
Product Code：B012065
English Name：Bumetanide Impurity 65
English Alias：3-amino-5-(N-butylsulfamoyl)-4-phenoxybenzoic acid
CAS No.：28328-60-1
Molecular Formula：C₁₇H₂₀N₂O₅S
Molecular Weight：364.42
High Purity：As a pharmaceutical impurity standard, it features precise chemical structure and stable physicochemical properties, meeting the strict requirements for qualitative and quantitative analysis of impurities in drug research and development, as well as quality control.
Strong Specificity：Closely related to the structure of Bumetanide, it can accurately simulate impurities that may be generated during drug synthesis or storage, providing a reliable basis for impurity tracing and control.
Drug Quality Research：Used for impurity analysis of Bumetanide bulk drugs and formulations, such as system suitability verification, quantitative standards, or qualitative reference substances in detection methods like HPLC and LC-MS.
R&D and Production Control：In the optimization of Bumetanide synthesis processes, it serves as an impurity reference substance to evaluate the impact of process routes on impurity formation, ensuring drug safety and compliance.
Bumetanide is a potent loop diuretic clinically used in the treatment of edematous diseases (such as heart failure, liver cirrhosis with ascites, etc.). The control of pharmaceutical impurities is a key link in the drug quality system. Bumetanide Impurity 65, as a potential impurity, may be generated from raw material residues, intermediate reactions, or by-products during drug synthesis. Research on this impurity helps improve the quality standards of drugs and ensure medication safety.
Current research on this impurity mainly focuses on the field of pharmaceutical analysis, including the establishment of detection methods for it in Bumetanide samples (such as optimization of separation conditions in high-performance liquid chromatography), and evaluation of its stability under different storage conditions. In addition, during the drug research and development stage, studies on the toxicity and pharmacological effects of this impurity can further clarify its impact on drug safety, providing data support for formulating reasonable impurity limits.
NOTE！
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17320513646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!
China
